A Biomarker-chip Assay in Preserved Red Blood Cells for the Diagnosis of Alzheimer's Disease

Clinical trial NCT07307872 · COMPLETED

Trial details

NCT number: NCT07307872
Sponsor: Amoneta Diagnostics SAS
Status: COMPLETED
Study type: OBSERVATIONAL

Alzheimer's Disease (AD)Neurodegenerative Disease Dementia Frontotemporal Dementia (FTD)

Start date: 2017-03-23
Primary completion: 2018-12-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.